Commitments and Contingencies (Tables)

9 Months Ended

Sep. 30, 2016

Milestones	Payments

(1) when Company initiates a Phase 1 Clinical Trial of a licensed product	$	750,000
(2) when Company initiates a Phase 2 Clinical Trial of a licensed product		750,000
(3) when Company initiates a Phase 3 Clinical Trial of a licensed product		1,500,000
(4) Biological License Application filing with U.S. FDA		1,750,000
(5) First commercial sale		1,500,000
(6) after the first $10,000,000 in net sales		1,500,000

For the year ending September 30, 2017	$	225,840
For the year ending September 30, 2018		199,440
For the year ending September 30, 2019		49,860
Total	$	475,140